CN115804805A - Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag - Google Patents
Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag Download PDFInfo
- Publication number
- CN115804805A CN115804805A CN202211702614.5A CN202211702614A CN115804805A CN 115804805 A CN115804805 A CN 115804805A CN 202211702614 A CN202211702614 A CN 202211702614A CN 115804805 A CN115804805 A CN 115804805A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- ankylosing spondylitis
- treating ankylosing
- external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 206010002556 Ankylosing Spondylitis Diseases 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 11
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 8
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 7
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000758794 Asarum Species 0.000 claims abstract description 7
- 241000488974 Loranthus Species 0.000 claims abstract description 7
- 241000195954 Lycopodium clavatum Species 0.000 claims abstract description 7
- 229910052891 actinolite Inorganic materials 0.000 claims abstract description 7
- 229940116229 borneol Drugs 0.000 claims abstract description 7
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 7
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 6
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 6
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 6
- 230000003071 parasitic effect Effects 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 6
- 241000208682 Liquidambar Species 0.000 claims description 5
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 241000173529 Aconitum napellus Species 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 229940023019 aconite Drugs 0.000 claims description 2
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000008035 Back Pain Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 241000213006 Angelica dahurica Species 0.000 description 3
- 206010061876 Obstruction Diseases 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 241000427159 Achyranthes Species 0.000 description 2
- 241001254604 Angelica pubescens Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 235000003717 Boswellia sacra Nutrition 0.000 description 2
- 235000012035 Boswellia serrata Nutrition 0.000 description 2
- 240000007551 Boswellia serrata Species 0.000 description 2
- 240000007311 Commiphora myrrha Species 0.000 description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 description 2
- 241000241550 Cyathula Species 0.000 description 2
- 241000123589 Dipsacus Species 0.000 description 2
- 241000208688 Eucommia Species 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 241000830535 Ligustrum lucidum Species 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 241000405414 Rehmannia Species 0.000 description 2
- 241001300193 Speranskia Species 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000011202 Angiopteris lygodiifolia Nutrition 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 235000017965 Asarum canadense Nutrition 0.000 description 1
- 244000306301 Caesalpinia sappan Species 0.000 description 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- 241001256368 Clematis chinensis Species 0.000 description 1
- 235000000385 Costus speciosus Nutrition 0.000 description 1
- 241000234276 Curculigo Species 0.000 description 1
- 241000723185 Cyathea Species 0.000 description 1
- 229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
- 241001116742 Drynaria Species 0.000 description 1
- 241000893536 Epimedium Species 0.000 description 1
- 235000014066 European mistletoe Nutrition 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 241000229179 Ledebouriella Species 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 235000008898 Morinda citrifolia Nutrition 0.000 description 1
- 244000131360 Morinda citrifolia Species 0.000 description 1
- 235000008248 Morinda citrifolia var citrifolia Nutrition 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 description 1
- 244000081426 Ranunculus ficaria Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 244000152640 Rhipsalis cassutha Species 0.000 description 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 1
- 241001180876 Saposhnikovia Species 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- 240000001638 Scurrula parasitica Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000913745 Spatholobus Species 0.000 description 1
- 241000316342 Taxillus Species 0.000 description 1
- 241000606265 Valeriana jatamansi Species 0.000 description 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 244000132619 red sage Species 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
A traditional Chinese medicine compound composition for treating ankylosing spondylitis and an external medicine bag belong to the technical field of traditional Chinese medicine compound for treating ankylosing spondylitis, and comprise 15-25g of parasitic loranthus, 15-25g of radix achyranthis bidentatae, 5-15g of cassia twig, 5-20g of lycopodium clavatum, 5-15g of safflower, 5-15g of folium artemisiae argyi, 5-20g of garden balsam stem, 10-15g of radix aconiti lateralis preparata, 5-15g of radix aconiti, 10g of asarum, 5-15g of fructus liquidambaris, 5-15g of borneol, 10-15g of cortex acanthopanacis, 10-15g of wooly datchmanspipe herb, 5-10g of fructus polygoni orientalis and 25-35g of actinolite. The traditional Chinese medicine composition is prepared according to the principle of monarch, minister, assistant and guide components, and has the effects of tonifying kidney, strengthening governor meridian, warming and activating meridian, and promoting blood circulation to arrest pain. Meanwhile, the external medicine bag can penetrate into the human body through the channels and collaterals on the body surface of the human body, thereby playing a better treatment role.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine compound for treating ankylosing spondylitis, and particularly relates to a traditional Chinese medicine compound composition for treating ankylosing spondylitis and an external medicine bag.
Background
Ankylosing Spondylitis (AS) is a common inflammatory rheumatic disease that affects the central axis skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional disorders and a decrease in quality of life. The incidence of AS in chinese populations is similar to that of white european population, about 0.24%. About 4% of patients lose part of their labor capacity 5 years after the onset of AS, and about 50% 45 years after the onset of AS. The pathogenesis of AS is unclear and may be related to genetics, infection, environment, immunity, etc. The key to the treatment is to relieve the inflammatory symptoms of AS patients AS soon AS possible, relieve pain, control disease activities, delay the progress of diseases and reduce teratogenic and disabling injuries of the patients caused by the diseases. However, the existing AS treatment medicines comprise non-steroidal anti-inflammatory drugs for improving the disease condition, immunosuppressants, antirheumatics, glucocorticoids and the like, and the long-term administration has large side effect, and causes adverse reactions such AS intolerance and influence on the liver and kidney functions of the gastrointestinal tract, thereby leading to heavy physical and psychological burdens of patients.
The traditional Chinese medicine can effectively improve the clinical symptoms of AS patients and reduce toxic and side effects, thereby further improving the life quality of the patients. Chinese patent application CN103893427A discloses a Chinese medicinal composition for treating ankylosing spondylitis and its preparation method, the composition is prepared from the following raw materials: kudzu root, chinese angelica, white paeony root, prepared rehmannia root, epimedium herb, deerhorn glue, chinese wolfberry, heterophylly falsestarwort root, incised notopterygium rhizome, doubleteeth pubescent angelica root, red paeony root, common macrocarpium fruit, chinese taxillus twig, himalayan teasel root, cassia twig, danshen root, suberect spatholobus stem, chinese wolfberry fruit, glossy privet fruit, desertliving cistanche, twotooth achyranthes root, fortune's drynaria rhizome, east Asian tree fern rhizome, eucommia bark, common curculigo rhizome, tuber fleeceflower root, medicinal indianmulberry root, glossy privet fruit, figwort root, costustoot, szechuan lovage rhizome, indian buead, large-leaved gentian, divaricate saposhnikovia root, medicinal cyathula root, manchurian wildginger, cassia twig, clematis root, prepared common monkshood mother root, prepared myrrh, prepared frankincense, liquoric root and pangolin. The traditional Chinese medicine composition has the advantages of safe propaganda and clinical application, no internal organ stimulation during oral administration, convenience in preparation and administration, guarantee of the purity of the medicine, convenience in storage, obvious curative effect, multiple absorption of effective components, good performance of medicine property, treatment of both symptoms and root causes, and total effective rate of 97%.
Chinese patent application CN106619988A discloses a traditional Chinese medicine foot-soaking powder for treating lumbocrural pain and a preparation method thereof, and the formula comprises: cassia twig, ledebouriella root, chinese mugwort leaf, schizonepeta tenuifolia, notopterygium root, pubescent angelica root, loranthus mulberry mistletoe, acanthopanax bark and safflower each 20g, eucommia bark, chinese angelica root, cinnamomum cassia, prepared rhizome of rehmannia, dipsacus root, buck grass, speranskia herb, dahurian angelica root, mulberry twig, sappan wood and Clematis chinensis each 30g, raw frankincense, raw myrrh, cyathula root and achyranthes root each 16g are added. The formulation of the foot bath powder is foot bath powder, and the foot bath powder has good treatment effect on lumbocrural pain.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine compound composition and an external medicine bag for treating ankylosing spondylitis, which are prepared according to the principle of monarch, minister, assistant and guide, and have the effects of tonifying kidney, strengthening governor vessel, warming channels, dredging collaterals, promoting blood circulation and relieving pain. Meanwhile, the external medicine bag can penetrate into the human body through the channels and collaterals on the body surface of the human body, thereby playing a better treatment role.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a traditional Chinese medicine compound composition for treating ankylosing spondylitis is prepared from the following traditional Chinese medicine raw materials in parts by weight:
15-25g of parasitic loranthus, 15-25g of radix achyranthis bidentatae, 5-15g of cassia twig, 5-20g of lycopodium clavatum, 5-15g of safflower, 5-15g of folium artemisiae argyi, 5-20g of garden balsam stem, 10-15g of aconite accessory piece, 5-15g of radix aconiti, 10g of asarum, 5-15g of beautiful sweetgum fruit, 5-15g of borneol, 10-15g of cortex acanthopanacis, 10-15g of wooly datchmanspipe herb, 5-10g of fructus polygoni orientalis and 25-35g of actinolite.
The treatment principle of the traditional Chinese medicine compound composition is as follows: tonifying kidney, strengthening Du channel, warming and activating meridian, promoting blood circulation, and relieving pain. The ankylosing spondylitis patients have the main symptoms of waist and back pain, belong to the category of arthralgia syndrome in traditional Chinese medicine, and have the main pathogenesis of obstruction causing pain, and the patients have the defects of spleen and kidney deficiency, insufficient vital qi, easy invasion of exogenous factors, obstruction of qi and blood circulation, stasis caused by transformation and obstruction causing pain. Therefore, in the compound composition, the loranthus parasiticus and the radix achyranthis bidentatae are monarch drugs, can tonify liver and kidney and dispel wind-damp. Cassia twig, radix aconiti lateralis preparata, asarum, folium artemisiae argyi, radix aconiti, cortex acanthopanacis, fructus liquidambaris, berba aristolochiae mollissimae, speranskia herb and lycopodium clavatum are used as ministerial drugs for dispelling wind-damp and stopping arthralgia. Safflower and fructus polygoni orientalis have the functions of promoting blood circulation, removing blood stasis and relieving pain, actinolite tonifies the kidney and dispels the cold, and are used as adjuvant drugs, borneol is pungent and thorough in flavor, clears the orifices and relieves the pain, and white spirit activates the blood circulation and channels to guide the drugs to the disease sites. The external treatment method is that the external medicine bag penetrates into the human body through the channels and collaterals on the surface of the human body to play a role in treatment, so that the external medicine bag is better favorable for treating the ankylosing spondylitis.
As a preferred technical scheme of the traditional Chinese medicine compound composition for treating ankylosing spondylitis, the traditional Chinese medicine compound composition is prepared from the following traditional Chinese medicine raw materials in parts by weight:
20g of parasitic loranthus, 20g of radix achyranthis bidentatae, 10g of cassia twig, 10g of lycopodium clavatum, 10g of safflower, 10g of folium artemisiae argyi, 10g of garden balsam stem, 10g of radix aconiti lateralis preparata, 10g of radix aconiti, 10g of asarum, 10g of beautiful sweetgum fruit, 10g of borneol, 10g of cortex acanthopanacis, 10g of wooly datchmanspipe herb, 10g of fructus polygoni orientalis and 30g of actinolite.
The invention also provides an external medicine bag prepared by the traditional Chinese medicine compound composition, which is prepared by crushing the traditional Chinese medicines, spraying a proper amount of white spirit into the medicine powder, uniformly mixing the medicine powder and putting the medicine powder into a cloth bag.
The traditional Chinese medicine compound composition can be used for treating ankylosing spondylitis and has a good treatment effect. The prepared external medicine bag can penetrate into the human body through the channels and collaterals on the surface of the human body, thereby playing a better therapeutic role.
Detailed Description
The present invention will be described in further detail with reference to the following examples and accompanying drawings.
Example 1
The externally applied medicine package for treating ankylosing spondylitis:
the compound composition is as follows: 20g of parasitic loranthus, 20g of radix achyranthis bidentatae, 10g of cassia twig, 10g of lycopodium clavatum, 10g of safflower, 10g of folium artemisiae argyi, 10g of garden balsam stem, 10g of radix aconiti lateralis preparata, 10g of radix aconiti, 10g of asarum, 10g of beautiful sweetgum fruit, 10g of borneol, 10g of cortex acanthopanacis, 10g of wooly datchmanspipe herb, 10g of fructus polygoni orientalis and 30g of actinolite.
The preparation method comprises the following steps: pulverizing the above Chinese medicinal materials, spraying 200g Chinese liquor into the medicinal powder, mixing the medicinal powder uniformly, and placing into a cloth bag to obtain the topical medicinal bag.
Before use, the product is placed into a microwave oven to be heated for 3 minutes and then placed on the back of a patient with ankylosing spondylitis for hot compress.
Example 2
Statistics of therapeutic effects
60 patients with ankylosing spondylitis (outpatients of first subsidiary hospital of university of traditional Chinese medicine in Anhui province) were treated with the external use medicine package prepared according to the method of example 1; 56 men and 4 women with the age of 20-28 years and the average age of 24 years. The course of disease is 0.5-5 years. The clinical manifestations are evaluation criteria of curative effects such as low back pain, stiffness, limited movement and the like:
(1) And curing: after the external medicine bag is used for treating 2 courses of treatment, the pain symptom of the patient disappears, and the joint can move normally;
(2) And the effectiveness is as follows: after the external medicine bag is used for treating 2 courses of treatment, the pain symptoms of the patient basically disappear, and the joint mobility is improved;
(3) And (3) invalidation: after 2 courses of external treatment, pain and joint limitation were not improved or even aggravated.
The result of the curative effect evaluation is as follows:
after 60 patients with ankylosing spondylitis are treated by using the external medicine bag for 2 treatment courses, 4 patients are cured, 52 patients are effective, and 4 patients are ineffective. The total effective rate is very remarkable.
Example 3
Typical cases
Case 1
For a certain period, male, age 26, lumbago and back pain for more than 2 years, no clear inducement before 2 years, obvious nighttime pain, soreness and weakness of waist and knees, aggravation after weather change and fatigue, obvious fatigue and hypodynamia, confirmed diagnosis as ankylosing spondylitis after perfect related examination, no obvious pain in waist and back, insomnia and no symptom repeated attack after 2 courses of treatment by using an externally-applied medicine bag.
Case 2
Von, male, 25 years old, repeated pain in the back and waist for 4 years, obvious pain in the back and waist at night, stiffness in the morning and relief after activities. After 2 courses of treatment with the external-use medicine bag, the symptoms of the pain of the waist and the back gradually disappear without relapse.
Case 3
Liu Zhi, female, 28 years old, recovery of pain in the waist and back for 3 years, obvious pain in the waist and back and obvious pain at night. After taking a plurality of medicines, a plurality of treatment modes (acupuncture, massage and the like) are tried, the treatment effect is not obvious, and after 2 treatment courses of external medicine bags, the symptoms of waist and back pain gradually disappear and the disease does not relapse.
The foregoing is merely exemplary and illustrative of the principles of the present invention and various modifications, additions and substitutions of the specific embodiments described herein may be made by those skilled in the art without departing from the principles of the present invention or exceeding the scope of the claims set forth herein.
Claims (5)
1. A traditional Chinese medicine compound composition for treating ankylosing spondylitis is characterized by being prepared from the following traditional Chinese medicine raw materials in parts by weight:
15-25g of parasitic loranthus, 15-25g of radix achyranthis bidentatae, 5-15g of cassia twig, 5-20g of lycopodium clavatum, 5-15g of safflower, 5-15g of folium artemisiae argyi, 5-20g of garden balsam stem, 10-15g of aconite accessory piece, 5-15g of radix aconiti, 10g of asarum, 5-15g of beautiful sweetgum fruit, 5-15g of borneol, 10-15g of cortex acanthopanacis, 10-15g of wooly datchmanspipe herb, 5-10g of fructus polygoni orientalis and 25-35g of actinolite.
2. The traditional Chinese medicine compound composition of claim 1, which is prepared from the following traditional Chinese medicine raw materials in parts by weight:
20g of parasitic loranthus, 20g of radix achyranthis bidentatae, 10g of cassia twig, 10g of lycopodium clavatum, 10g of safflower, 10g of folium artemisiae argyi, 10g of garden balsam stem, 10g of radix aconiti lateralis preparata, 10g of radix aconiti, 10g of asarum, 10g of beautiful sweetgum fruit, 10g of borneol, 10g of cortex acanthopanacis, 10g of wooly datchmanspipe herb, 10g of fructus polygoni orientalis and 30g of actinolite.
3. The external medicine package prepared by the compound traditional Chinese medicine composition of claim 1 or 2, which is characterized in that the external medicine package is obtained by crushing the traditional Chinese medicines, spraying a proper amount of white spirit into the medicine powder, uniformly mixing the medicine powder and putting the medicine powder into a cloth bag.
4. The use of the compound Chinese medicinal composition of claim 1 or 2 in the preparation of a medicament for treating ankylosing spondylitis.
5. Use of the external pharmaceutical pack according to claim 3 for the preparation of a medicament for treating ankylosing spondylitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211702614.5A CN115804805B (en) | 2022-12-29 | 2022-12-29 | Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211702614.5A CN115804805B (en) | 2022-12-29 | 2022-12-29 | Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115804805A true CN115804805A (en) | 2023-03-17 |
| CN115804805B CN115804805B (en) | 2023-10-27 |
Family
ID=85487080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211702614.5A Active CN115804805B (en) | 2022-12-29 | 2022-12-29 | Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115804805B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202008002953U1 (en) * | 2008-03-01 | 2008-07-03 | Reither, Robert, Dr. | Chinese herbal recipes for the treatment of musculoskeletal disorders in humans and animals |
| CN104096022A (en) * | 2014-07-29 | 2014-10-15 | 张宗云 | External use compound Chinese herbal preparation for treating ankylosing spondylitis and preparation method thereof |
| CN106389720A (en) * | 2016-10-25 | 2017-02-15 | 李本虎 | Medicine for treating ankylosing spondylitis and preparation method thereof |
-
2022
- 2022-12-29 CN CN202211702614.5A patent/CN115804805B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202008002953U1 (en) * | 2008-03-01 | 2008-07-03 | Reither, Robert, Dr. | Chinese herbal recipes for the treatment of musculoskeletal disorders in humans and animals |
| CN104096022A (en) * | 2014-07-29 | 2014-10-15 | 张宗云 | External use compound Chinese herbal preparation for treating ankylosing spondylitis and preparation method thereof |
| CN106389720A (en) * | 2016-10-25 | 2017-02-15 | 李本虎 | Medicine for treating ankylosing spondylitis and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 庞立波, 王素美, 丁立钧, 金新美: "中药熏蒸治疗强直性脊柱炎临床观察", 山东中医杂志, vol. 22, no. 04, pages 208 * |
| 李晓妮;杨淑彬;: "止痹方蒸气浴治疗强直性脊柱炎43例", 陕西中医, vol. 34, no. 07, pages 847 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115804805B (en) | 2023-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN110721219A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN100584354C (en) | A medicine for treating zoster sequela neuralgia | |
| CN104258278A (en) | Gushangling (for bone injury) spray | |
| CN101274024B (en) | Pharmaceutical compositions for curing toothache | |
| CN112915173A (en) | Traditional Chinese medicine composition for treating orthopedic diseases, preparation method and application | |
| CN115804805A (en) | Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag | |
| CN103356932A (en) | Medicine composition for treating vulva squamous cell hyperplasia | |
| CN114028507A (en) | Preparation method of traditional Chinese medicine for treating lumbago | |
| CN112618626A (en) | Traditional Chinese medicine spray for treating herpes zoster and preparation method thereof | |
| CN110448601B (en) | Traditional Chinese medicine composition for treating migraine | |
| CN115887601B (en) | A composition for treating hemorrhoid and its preparation method | |
| CN115192689B (en) | Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain, application and traditional Chinese medicine preparation thereof | |
| CN102068647A (en) | Chinese medicinal composition for treating lumbocrural pains by ironing and warming | |
| CN106309576A (en) | Drug for treating haemorrhoids and preparation method thereof | |
| CN106039213A (en) | Paste capable of dispelling wind and removing obstruction in meridians so as to alleviate pain | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN115089653A (en) | Traditional Chinese medicine composition for treating rheumatism and cervical and lumbar diseases and application thereof | |
| CN105125714A (en) | Traditional Chinese medicine preparation for treating chemotherapeutic phlebitis and preparing method thereof | |
| CN105920120B (en) | Medicine composition for treating oral mucositis caused by tumor and preparation method thereof | |
| CN104971209A (en) | Externally used agent for treating tinea pedis and preparation method thereof | |
| CN112972611A (en) | Pharmaceutical composition for treating hemolytic anemia and application thereof | |
| CN115252679A (en) | Traditional Chinese medicine composition for treating ischemic cardiomyopathy and application thereof | |
| CN103751464B (en) | A kind of Chinese medicine composition for the treatment of lumbar muscle strain and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |